Senestech (SNES) Q3 2024 earnings summary

Executive summary

• Achieved record quarterly revenue and gross margin in Q3 2024, with nine-month revenue up 51% year-over-year to $1.4 million, driven by strong adoption of Evolve Rat and Evolve Mouse products.

• Evolve Rat, launched less than a year ago, accounted for 52% of Q3 2024 revenue; Evolve Mouse, launched in May, contributed 17%.

• Gross margin reached 65% in Q3 2024, up from 49% in Q3 2023, reflecting manufacturing efficiencies and favorable product mix.

• Operating expenses decreased 12% year-over-year in Q3 2024, reflecting improved efficiency and cost control.

• Net loss for Q3 2024 was $1.5 million, a 22% improvement year-over-year; adjusted EBITDA loss was the smallest in company history.

Financial highlights

• Q3 2024 revenue was $482,000, up 34% year-over-year; nine-month revenue reached $1.36 million, up 51%.

• Q3 2024 gross profit was $315,000, a 79% increase from Q3 2023; gross margin reached 65%.

• Net loss for Q3 2024 was $1.51 million, improved from $1.95 million in Q3 2023; nine-month net loss was $4.93 million, improved from $5.98 million.

• Adjusted EBITDA loss for Q3 2024 was $1.42 million, improved from $1.79 million in Q3 2023.

• Cash and cash equivalents were $2.5 million as of September 30, 2024.

Outlook and guidance

• Anticipates top-line growth in Q4 2024 from e-commerce expansion, large international orders, and new retail placements.

• Expects to achieve cash flow break-even in 2025, supported by margin improvements and revenue growth.

• Cash and equivalents plus anticipated revenue and equity sales expected to fund operations for at least four months from September 30, 2024; additional financing will be needed before profitability.

• Ongoing expansion into new markets and channels, including regulatory approvals in more states and countries.

• Expenses expected to continue or increase as commercialization and R&D efforts expand.